|
|
 |
|
Viewing report
|
|
|
|
Indian Pharma Industry Monitor
ILogy Healthcare Solutions, Aug 2008, Pages: 16
The Indian Pharma Review gives a summary and analysis of the Indian pharma market including, mergers, acquisitions, divestments, major pharma deals and strategic collaborations, clinical trial highlights, and pipeline advancements during April-June, 2008. The report also contains a brief financial review and statistical comparison of the quarterly performances of the top ten pharma companies. It also covers the current scenario and future trends both at the financial and business levels. It is widely subscribed by leading indian pharma industry professionals, strategy advisors, and other key decision makers.
The Indian pharma industry had remained highly dynamic and competitive during the second quarter of the calendar year 2008 through major acquisitions and collaborations. The quarter also witnessed cost effective drugs developed by major pharma companies entering into the generic markets of other countries including South Africa and Japan, apart from US. Indian pharma giants such as Ranbaxy, Strides, and Lupin are mainly targeting on the US generic market to strengthen their foothold. Surge in production of generics, acquisition of foreign pharma companies, and collaboration between domestic players are greatly accelerating the growth of the Indian pharma sector.
Customers who bought this item also bought
Indian Pharma Industry Monitor
Indian Lubricants Industry 2008
Indian Pharmaceutical Industry: Issues and Opportunities
Growth Opportunities in the Indian Composites Market 2004-2010
Analyzing the Indian Pharmaceutical Industry
Analyzing the Indian Steel Industry
Analyzing the Indian Retail Industry
Indian Construction Industry: An Analysis
|
|
|
|
